OLMA - Olema Pharmaceuticals, Inc.
NEXT EARNINGS:
Mar 17, 2026
(in 20 days)
EPS Est: $-0.51
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$43.38
DETAILS
HIGH:
$48.00
LOW:
$38.00
MEDIAN:
$44.00
CONSENSUS:
$43.38
UPSIDE:
75.70%
Market Cap:
1.94B
Volume:
1,612,239
Avg Volume:
1,952,990
52 Week Range:
2.86-36.259
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.92
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
96
IPO Date:
2020-11-19
EPS (TTM):
-2.20
P/E Ratio:
-2.65
Revenue (TTM):
N/A
Total Assets:
450.98M
Total Debt:
1.43M
Cash & Equiv:
139.48M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-34.8%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $-0.49 | $-0.44 | -11.4% | — | — | — |
| 2025-08-11 | $-0.51 | $-0.43 | -18.6% | — | — | — |
| 2025-05-13 | $-0.36 | $-0.49 | +26.5% | — | — | — |
| 2025-03-18 | $-0.51 | $-0.63 | +19.0% | — | — | — |
| 2024-11-12 | $-0.60 | $-0.59 | -1.7% | — | — | — |
| 2024-08-06 | $-0.54 | $-0.54 | 0.0% | — | — | — |
| 2024-05-08 | $-0.56 | $-0.53 | -5.7% | — | — | — |
| 2024-03-11 | $-0.49 | $-0.49 | 0.0% | $1.9M | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (129.47M) | (96.66M) | (104.79M) | (71.10M) | (22.12M) | (4.32M) | (2.20M) |
| EPS | -2.20 | -2.14 | -2.62 | -1.79 | -0.58 | -0.11 | -0.16 |
| Total Assets | 450.98M | 276.94M | 215.65M | 295.94M | 342.72M | 132,000 | 3.27M |
| Total Debt | 1.43M | 2.42M | 2.56M | 3.29M | 0 | 0 | 0 |
| Cash & Equivalents | 139.48M | 68.54M | 23.70M | 13.81M | 338.55M | 68,000 | 3.15M |
| Operating Cash Flow | (104.35M) | (83.73M) | (82.06M) | (50.69M) | (19.87M) | (3.08M) | (2.18M) |
| Free Cash Flow | (104.51M) | (83.73M) | (82.43M) | (52.27M) | (19.92M) | (3.08M) | (2.18M) |
| FCF per Share | -1.78 | -1.85 | -2.06 | -1.32 | -0.51 | -0.08 | -0.15 |
| Book Value | 408.96M | 253.90M | 197.55M | 284.57M | 338.14M | (10.59M) | (6.28M) |
| Cash & ST Investments | 434.09M | 261.81M | 204.42M | 287.25M | 338.55M | 68,000 | 3.15M |
| ROC Equity | -0.32 | -0.38 | -0.53 | -0.25 | -0.07 | N/A | N/A |